These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23651939)

  • 1. Assessing the quality of VA Human Research Protection Programs: VA vs. affiliated University Institutional Review Board.
    Tsan MF; Nguyen Y; Brooks R
    J Empir Res Hum Res Ethics; 2013 Apr; 8(2):153-60. PubMed ID: 23651939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials.
    Tsan MF; Tsan LW
    Clin Trials; 2015 Jun; 12(3):224-31. PubMed ID: 25631384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economies of scale in institutional review boards.
    Wagner TH; Cruz AM; Chadwick GL
    Med Care; 2004 Aug; 42(8):817-23. PubMed ID: 15258484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Compliance With Institutional Review Board Continuing Review Requirements.
    Tsan MF; Nguyen Y
    J Empir Res Hum Res Ethics; 2019 Oct; 14(4):365-371. PubMed ID: 30894051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time required to review research protocols at 10 Veterans Affairs Institutional Review Boards.
    Varley PR; Feske U; Gao S; Stone RA; Zhang S; Monte R; Arnold RM; Hall DE
    J Surg Res; 2016 Aug; 204(2):481-489. PubMed ID: 27565086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the quality of human research protection programs: the experience at the Department of Veterans Affairs.
    Tsan MF; Smith K; Gao B
    IRB; 2010; 32(4):16-9. PubMed ID: 20853799
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an institutional review board preapproval process for Doctor of Nursing Practice students: process and outcome.
    Szanton SL; Taylor HA; Terhaar M
    J Nurs Educ; 2013 Jan; 52(1):51-5. PubMed ID: 23230884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
    Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
    Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 12. Research ethics boards: no data on quality of for-profit or non-profit IRBs.
    Shamoo AE; Woeckner E
    PLoS Med; 2006 Oct; 3(10):e459; author reply e460, e471. PubMed ID: 17076572
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of Human Research Protection Program Performance Measurements.
    Tsan MF; Nguyen Y
    J Empir Res Hum Res Ethics; 2017 Oct; 12(4):217-228. PubMed ID: 28758521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Institutional Review processes for a multisite observational study.
    Vick CC; Finan KR; Kiefe C; Neumayer L; Hawn MT
    Am J Surg; 2005 Nov; 190(5):805-9. PubMed ID: 16226962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
    Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
    Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional review board guidance on pediatric research: missed opportunities.
    Wolf LE; Zandecki J; Lo B
    J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New guidance on reviews by central institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 May; 20(5):1-2. PubMed ID: 16175714
    [No Abstract]   [Full Text] [Related]  

  • 19. The development and acceptance of a simple tool to aid IRB compliance.
    Vulcano DM
    Qual Manag Health Care; 2012; 21(3):203-8. PubMed ID: 22722526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How variability in the institutional review board review process affects minimal-risk multisite health services research.
    Petersen LA; Simpson K; Sorelle R; Urech T; Chitwood SS
    Ann Intern Med; 2012 May; 156(10):728-35. PubMed ID: 22586010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.